Conversational Agents for Asthma and Chronic Obstructive Pulmonary Disease Management: Scoping Review
Conversational Agents für das Management von Asthma und chronisch obstruktiver Lungenerkrankung: Scoping Review
Journal of Medical Internet Research · 29.09.2026 · 28 · e98338-e98338
DOI: 10.2196/98338 ↗Auf einen Blick
Die Literatur zu Conversational Agents bei Asthma und COPD wurde kartiert. Die Evidenz ist früh entwickelt und liefert nur begrenzte Hinweise auf klinische Effekte.
Fragestellung
Welche Literatur gibt es zum Einsatz von Conversational Agents bei Asthma und COPD, welche Rollen, Outcomes und Studiendesigns wurden beschrieben?
Methode
Scoping Review nach Arksey und O’Malley; 9 Datenbanken vom 1. Januar 2014 bis 22. Februar 2025; Analyse nach PAGER, Berichterstattung nach PRISMA-ScR.
Ergebnisse
6275 Treffer gescreent, 16 Berichte aus 15 Studien eingeschlossen. CAs dienten der Information, Patientenedukation, Datenerhebung sowie emotionaler oder motivierender Unterstützung. Nur 4 Studien erhoben direkte klinische Outcomes.
Einschränkungen
Meist kleine Machbarkeits-, Entwicklungs- und Pilotstudien; gemischte Usability- und Zufriedenheitsbefunde; begrenzte Evidenz zu klinischen Outcomes.
Schlussfolgerung der Autor:innen
Die Evidenz zu CAs bei Asthma und COPD ist noch in einem frühen Entwicklungsstadium und erlaubt derzeit nur begrenzte Aussagen zur Wirksamkeit.
Kernaussagen
- CAs wurden für Information, Edukation, Datenerhebung und Unterstützung eingesetzt.
- Nur 4 Studien maßen direkte klinische Outcomes.
- Usability und Zufriedenheit waren gemischt; Vertrauen und Personalisierung waren wiederkehrende Themen.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Scoping Review in der Zeitschrift Journal of Medical Internet Research, online erschienen am 29.09.2026. Verfasst von Nurfaizah Binte Hassan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, National University Hospital, National University Health System, Singapore, Singapore. Hauptthemen laut MEDLINE: Asthma, Communication, Pulmonary Disease, Chronic Obstructive, Generative Artificial Intelligence. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: COPD
Abstract (Originalsprache)
Background
Asthma and chronic obstructive pulmonary disease (COPD) affect more than 650 million people worldwide and remain leading causes of disability, with a rising burden as populations age. Conversational agents (CAs) may offer a more interactive alternative. However, the evidence in obstructive lung disease has not been mapped.
Objective
The aim of this study is to map the literature on CA use in asthma and COPD, to describe the roles they have been designed to perform, the outcomes that have been measured, and to map the study designs and methods characterizing the current evidence.
Methods
A scoping review was conducted following the Arksey and O’Malley framework. A total of 9 databases (CINAHL, CENTRAL, Embase, IEEE Xplore, PubMed, ProQuest, Scopus, Web of Science, and Google Scholar) were searched from January 1, 2014, to February 22, 2025. Data were synthesized using inductive content analysis and organized via the Patterns, Advances, Gaps, Evidence for Practice, and Research Recommendations (PAGER) framework. Reporting followed PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines.
Results
A total of 6275 records were screened, and 16 reports from 15 studies were included. Studies reported CAs being used for information provision and patient education, health data collection, and emotional or motivational support. Only 4 studies measured direct clinical outcomes (eg, asthma control or medication adherence). Reported usability and satisfaction findings were mixed, with recurring concerns about conversational flow, responsiveness, trust, and personalization.
Conclusions
The evidence base for CAs in asthma and COPD remains in early developmental stages. It consists mainly of small feasibility, developmental, and pilot studies, providing limited evidence on whether CAs improve clinical outcomes. Current evidence can mainly describe the roles CAs have been designed to perform and the user-experience factors that influence engagement. Adequately powered, longitudinal trials using clinically meaningful and standardized endpoints are required before effectiveness can be assessed. Future development should place patients, as the end users, at the center of co-design, with clinicians, including nurses, involved to ensure clinical relevance and safe integration into care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nursing, National University Hospital, National University Health System, Singapore, Singapore.
- Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Block MD6, Level 5, 14 Medical Drive, Singapore, 117599, Singapore, +65 6516 7791.
- Division of Respiratory and Critical Care Medicine, Alexandra Hospital, National University Health System, Singapore, Singapore.
- Division of Respiratory and Critical Care Medicine, Department of Medicine, National University Hospital, National University Health System, Singapore, Singapore.
- National University Polyclinics, National University Health System, Singapore, Singapore.
- Group Chairman Medical Board Office, National University Health System, Singapore, Singapore.
Zitieren
APA
Hassan, N. B., Teo, T. P., Liew, M. F., Tan, W. H., Wu, W., Tan, T. M., Mustafah, S. A. B., Poh, D. W. Q., He, H. G., Khor, J. H., Tan, G. M. Y., Yoong, S. Q., & Jiang, Y. (2026). Conversational Agents for Asthma and Chronic Obstructive Pulmonary Disease Management: Scoping Review. Journal of Medical Internet Research, 28, e98338-e98338. https://doi.org/10.2196/98338
Vancouver
Hassan NB, Teo TP, Liew MF, Tan WH, Wu W, Tan TM, et al. Conversational Agents for Asthma and Chronic Obstructive Pulmonary Disease Management: Scoping Review. Journal of Medical Internet Research. 2026;28:e98338-e98338. doi:10.2196/98338
BibTeX
@article{Hassan2026,
author = {Hassan, Nurfaizah Binte and Teo, Tiang Peng and Liew, Mei Fong and Tan, Wee Hian and Wu, Wenjie and Tan, Timotius Marvin and Mustafah, Siti Aisah Binte and Poh, Deborah Wan Qin and He, Hong-Gu and Khor, Joanne Huiyi and Tan, Genevieve Mei Yun and Yoong, Si Qi and Jiang, Ying},
title = {Conversational Agents for Asthma and Chronic Obstructive Pulmonary Disease Management: Scoping Review},
journal = {Journal of Medical Internet Research},
year = {2026},
volume = {28},
pages = {e98338--e98338},
doi = {10.2196/98338}
}
EUVIMED